Ovation Science Inc.
OVATF
$0.04
-$0.04-53.95%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -27.30% | -41.57% | -44.78% | -38.35% | 42.67% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -27.30% | -41.57% | -44.78% | -38.35% | 42.67% |
| Cost of Revenue | 268.52% | 0.00% | -71.19% | -83.86% | -81.25% |
| Gross Profit | -54.01% | -54.94% | -30.06% | -10.52% | 253.85% |
| SG&A Expenses | 22.53% | 13.54% | -28.37% | -33.42% | -35.03% |
| Depreciation & Amortization | -- | -- | -100.00% | -83.33% | -58.33% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 24.87% | 10.08% | -28.76% | -34.88% | -37.61% |
| Operating Income | -35.72% | -22.28% | 25.73% | 34.35% | 44.16% |
| Income Before Tax | -53.02% | -34.50% | 36.96% | 31.86% | 53.67% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -53.02% | -34.50% | 36.96% | 31.86% | 53.67% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -53.02% | -34.50% | 36.96% | 31.86% | 53.67% |
| EBIT | -35.72% | -22.28% | 25.73% | 34.35% | 44.16% |
| EBITDA | -13.52% | -22.52% | 25.72% | 34.35% | 44.25% |
| EPS Basic | -44.71% | -28.28% | 39.72% | 38.56% | 57.50% |
| Normalized Basic EPS | -41.51% | -25.81% | 42.22% | 40.82% | 58.59% |
| EPS Diluted | -44.71% | -28.28% | 39.72% | 38.56% | 57.50% |
| Normalized Diluted EPS | -41.51% | -25.81% | 42.22% | 40.82% | 58.59% |
| Average Basic Shares Outstanding | 7.79% | 5.84% | 6.43% | 11.38% | 6.94% |
| Average Diluted Shares Outstanding | 7.79% | 5.84% | 6.43% | 11.38% | 6.94% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |